IRYCIS Outstanding publication

• Tuesday, 14 October 2025

  Monreal E, Fernández JI, Sainz de la Maza S, Espiño M, Villarrubia N, Roldán E, Aladro Y, Cuello JP, Ayuso L, Rodero A, Chico JL, Rodríguez F, Quiroga A, Rodríguez E, Pilo de la Fuente B, Martín G, Martínez ML, García JM, Rubio L, Llufriu S, Comabella M, Montalban X, Álvarez G, Veiga JL, Masjuan J, Costa L, Villar LM. Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis

  Int J Mol Sci. 2025

  10.3390/ijms26146898

• Tuesday, 7 October 2025

  Bayona A, Nattero L, De la Calle E, Quintero A, de Lope S, Dorado B, Fiers T, Kaufman JM, Luque M, Escobar HF. Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes

  Hum Reprod Open. 2025

  10.1093/hropen/hoaf048

• Tuesday, 30 September 2025

  Sánchez Carretero L, Cardeñosa Pérez ÀC, Peces-Barba G, Pérez-Rial S. Differential lung gene expression identified Zscan2 and Bag6 as novel tissue repair players in an experimental COPD model

  PLoS One. 2024

  10.1371/journal.pone.0309166

• Tuesday, 23 September 2025

  Domínguez-Rodríguez LM, Dobarro D, Iglesias C, Crespo MG, Raposeiras S, Álvarez J, Barreiro M, Muñoz I, Sánchez A, Íñiguez Á, Zamorano JL. Guideline-directed medical therapy for heart failure in arrhythmia-induced cardiomyopathy with improved left ventricular ejection fraction

  Eur J Heart Fail. 2024

  10.1002/ejhf.3556